These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

571 related items for PubMed ID: 29218625

  • 1. Diuretic or Beta-Blocker for Hypertensive Patients Already Receiving ACEI/ARB and Calcium Channel Blocker.
    Tsai MS, Tang CH, Lin CY, Chuang PY, Chen NC, Huang CH, Chang WT, Wang TD, Yu PH, Chen WJ.
    Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):535-543. PubMed ID: 29218625
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin Receptor Blockers for Hypertension and Risk of Epilepsy.
    Wen X, Otoo MN, Tang J, Brothers T, Ward KE, Asal N, Meador KJ.
    JAMA Neurol; 2024 Aug 01; 81(8):866-874. PubMed ID: 38884986
    [Abstract] [Full Text] [Related]

  • 3. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
    Lee J, Lee S.
    Pharmacotherapy; 2018 Nov 01; 38(11):1095-1105. PubMed ID: 30225928
    [Abstract] [Full Text] [Related]

  • 4. Analysis of Dual Combination Therapies Used in Treatment of Hypertension in a Multinational Cohort.
    Lu Y, Van Zandt M, Liu Y, Li J, Wang X, Chen Y, Chen Z, Cho J, Dorajoo SR, Feng M, Hsu MH, Hsu JC, Iqbal U, Jonnagaddala J, Li YC, Liaw ST, Lim HS, Ngiam KY, Nguyen PA, Park RW, Pratt N, Reich C, Rhee SY, Sathappan SMK, Shin SJ, Tan HX, You SC, Zhang X, Krumholz HM, Suchard MA, Xu H.
    JAMA Netw Open; 2022 Mar 01; 5(3):e223877. PubMed ID: 35323951
    [Abstract] [Full Text] [Related]

  • 5. A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan.
    Wu LS, Chang SH, Chang GJ, Liu JR, Chan YH, Lee HF, Wen MS, Chen WJ, Yeh YH, Kuo CT, See LC.
    Cardiovasc Diabetol; 2016 Apr 02; 15():56. PubMed ID: 27039185
    [Abstract] [Full Text] [Related]

  • 6. Fixed-Dose Combinations of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in the Treatment of Hypertension: A Comparison of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors.
    Hsiao FC, Tung YC, Chou SH, Wu LS, Lin CP, Wang CL, Lin YS, Chang CJ, Chu PH.
    Medicine (Baltimore); 2015 Dec 02; 94(51):e2355. PubMed ID: 26705234
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antihypertensive treatment and risk of atrial fibrillation: a nationwide study.
    Marott SC, Nielsen SF, Benn M, Nordestgaard BG.
    Eur Heart J; 2014 May 02; 35(18):1205-14. PubMed ID: 24347316
    [Abstract] [Full Text] [Related]

  • 9. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S, Psaty B, Greenland P, Oberman A, Kotchen T, Mouton C, Black H, Aragaki A, Trevisan M.
    JAMA; 2004 Dec 15; 292(23):2849-59. PubMed ID: 15598916
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Real-World Effectiveness of Beta-Blockers versus Other Antihypertensives in Reducing All-Cause Mortality and Cardiovascular Events.
    Foch C, Allignol A, Hostalek U, Boutmy E, Hohenberger T.
    Int J Clin Pract; 2022 Dec 15; 2022():6124559. PubMed ID: 35989866
    [Abstract] [Full Text] [Related]

  • 12. Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease.
    Huang RS, Cheng YM, Zeng XX, Kim S, Fu P.
    Chin Med J (Engl); 2016 Mar 05; 129(5):562-9. PubMed ID: 26904991
    [Abstract] [Full Text] [Related]

  • 13. Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension: a randomized controlled trial.
    Matsuzaki M, Ogihara T, Umemoto S, Rakugi H, Matsuoka H, Shimada K, Abe K, Suzuki N, Eto T, Higaki J, Ito S, Kamiya A, Kikuchi K, Suzuki H, Tei C, Ohashi Y, Saruta T, Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial Group.
    J Hypertens; 2011 Aug 05; 29(8):1649-59. PubMed ID: 21610513
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin receptor blockers (ARB) outperform angiotensin-converting enzyme (ACE) inhibitors on ischemic stroke prevention in patients with hypertension and diabetes - A real-world population study in Taiwan.
    Pai PY, Muo CH, Sung FC, Ho HC, Lee YT.
    Int J Cardiol; 2016 Jul 15; 215():114-9. PubMed ID: 27111172
    [Abstract] [Full Text] [Related]

  • 15. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
    Hanon O, Laroche P, Vidal JS, Pannier B, Postel-Vinay N, Vaisse B, Girerd X.
    Ann Cardiol Angeiol (Paris); 2012 Jun 15; 61(3):218-23. PubMed ID: 22695025
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and the risk of major adverse cardiac events in patients with diabetes and prior stroke: a nationwide study.
    Shih CJ, Chen HT, Chao PW, Kuo SC, Li SY, Yang CY, Tarng DC, Ou SM, Chen YT.
    J Hypertens; 2016 Mar 15; 34(3):567-74; discussion 575. PubMed ID: 26703918
    [Abstract] [Full Text] [Related]

  • 17. Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers.
    Bakris GL, Cooper-Dehoff RM, Zhou Q, Kupfer S, Champion A, Pepine CJ, INVEST Investigators.
    Am J Cardiovasc Drugs; 2007 Mar 15; 7 Suppl 1():25-9. PubMed ID: 19845074
    [Abstract] [Full Text] [Related]

  • 18. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
    Talbert RL.
    J Am Pharm Assoc (2003); 2010 Mar 15; 50(5):e116-25. PubMed ID: 20833609
    [Abstract] [Full Text] [Related]

  • 19. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
    Petrella R, Michailidis P.
    Clin Ther; 2011 Sep 15; 33(9):1190-203. PubMed ID: 21885126
    [Abstract] [Full Text] [Related]

  • 20. Potentially Inappropriate Antihypertensive Prescriptions to Elderly Patients: Results of a Prospective, Observational Study.
    Márquez PHP, Torres OH, San-José A, Vidal X, Agustí A, Formiga F, López-Soto A, Ramírez-Duque N, Fernández-Moyano A, Garcia-Moreno J, Arroyo JA, Ruiz D, Potentially Inappropriate Prescription in Older Patients in Spain (PIPOPS) Investigators’ Project.
    Drugs Aging; 2017 Jun 15; 34(6):453-466. PubMed ID: 28432600
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.